AI-generated summary
Forty women with melasma and Fitzpatrick skin types II-III were treated with a low-fluence 1064 nm Q-switched Nd:YAG laser over nine sessions. The authors report significant reductions in melanin index, the modified Melasma Area Severity Index and erythema index, with 70% of participants satisfied, and maintained effect at one year in 21 patients. The authors describe the study as a small, single-group report without a control group.
- Participants
- 40
- Who or what was studied
- Forty Polish women with Fitzpatrick skin phototype II-III and melasma (Caucasian)
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- Small single-group study without a control group, with only 21 of 40 patients followed for one year.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
- Energy density (fluence)
- 3.2 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.